FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The Peptide Boom Is Getting Out of Hand The Atlantic BPC 157: Experimental Peptide Creates Risk for Athletes The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law